Even Low Levels of Exercise Can Lower CHD Risk in Young Women

Share this content:
Even Low Levels of Exercise Can Lower CHD Risk in Young Women
Even Low Levels of Exercise Can Lower CHD Risk in Young Women

TUESDAY, July 26, 2016 (HealthDay News) -- Younger women who exercise just 2.5 hours a week may cut their risk for coronary heart disease (CHD) by up to 25 percent, according to research published in the July 26 issue of Circulation.

Andrea Chomistek, Sc.D., an assistant professor of epidemiology and biostatistics at Indiana University's School of Public Health in Bloomington, and colleagues collected data on 97,230 women, aged 27 to 44, who took part in the Nurses' Health Study 2. Specifically, the researchers looked at the frequency, amount of time, intensity and type of preferred physical activity in which the women participated. During 20 years of follow-up, 544 women developed CHD.

The researchers found that women who were the most physically active during their leisure time had the lowest risk for CHD -- 25 percent lower than women who exercised the least. The reduced risk of CHD was also found with brisk walking alone. The women who seemed to benefit the most exercised the most, at least 150 minutes a week, with the benefits seen regardless of session frequency.

"These prospective data suggest that total volume of leisure-time physical activity is associated with lower risk of incident CHD among young women," the authors write. "In addition, this association was not modified by weight, emphasizing that it is important for normal weight, overweight, and obese women to be physically active."

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Kinase Inhibitor for Treatment of AML

FDA Approves Kinase Inhibitor for Treatment of AML

Midostaurin, in combination with chemotherapy, treats acute myeloid leukemia in adults

Enzyme Replacement Drug OK'd for Form of Batten Disease

Enzyme Replacement Drug OK'd for Form of Batten ...

Brineura will be used to treat children with late infantile neuronal ceroid lipofuscinosis type 2 Batten

is free, fast, and customized just for you!

Already a member?

Sign In Now »